Pharmaceuticals: Strategic Withdrawal
Dow Corning Corp., which pioneered silicone-gel breast implants in 1962, last week became the third manufacturer to abandon the market. The target of hundreds of lawsuits that could cost the company $1 billion, Dow Corning finally succumbed to the national furor that erupted over allegations that the implants can cause major health problems.
Even as the company withdrew, it insisted that there is no proof that leakage from Dow implants causes significant damage. But it announced a $10 million fund for research into implant questions and said it will pay up to $1,200 (of a cost that ranges from $500 to $5,000) for customers who cannot afford surgery for necessary removal.
Two companies still manufacture the implants, and a million American women continue to live with implants -- most without complaint.
Most Popular »
- Five Things the U.S. Can Learn from China
- The H1N1 Pandemic: Is a Second Wave Possible?
- Facebook's Secret Code
- Tiger Gets Mulligan from the TV Networks
- Protests Mount Against Israel's Settlement Freeze
- Why Is SNL's Andy Samberg Nominated for a Rap Grammy?
- The Growing Backlash Against Overparenting
- The Troubles at Kroger: Frugal Consumers
- The FBI Probe: What Went Wrong at Fort Hood?
- Uganda's Anti-Gay Bill: Inspired by the U.S.
- The H1N1 Pandemic: Is a Second Wave Possible?
- Remarks of President Barack Obama: Acceptance of the Nobel Peace Prize
- Tiger Gets Mulligan from the TV Networks
- The Troubles at Kroger: Frugal Consumers
- Should Wild Animals Become Pets to Ward Off Extinction?
- Facebook's Secret Code
- Obama Shrinks the War on Terrorism
- Uganda's Anti-Gay Bill: Inspired by the U.S.
- The Job Market: Is a College Degree Worth Less?
- Why Is SNL's Andy Samberg Nominated for a Rap Grammy?
Top Stories on TIME.com
Quotes of the Day »
RSS